112 related articles for article (PubMed ID: 7997244)
1. C3b covalently associated to tetanus toxin modulates TT processing and presentation by U937 cells.
Rey-Millet CA; Villiers CL; Gabert FM; Chesne S; Colomb MG
Mol Immunol; 1994 Dec; 31(17):1321-7. PubMed ID: 7997244
[TBL] [Abstract][Full Text] [Related]
2. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
3. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
Arvieux J; Yssel H; Colomb MG
Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
[TBL] [Abstract][Full Text] [Related]
4. Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production.
Serra VA; Cretin F; Pépin E; Gabert FM; Marche PN
Eur J Immunol; 1997 Oct; 27(10):2673-9. PubMed ID: 9368625
[TBL] [Abstract][Full Text] [Related]
5. Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells.
Villiers MB; Villiers CL; Jacquier-Sarlin MR; Gabert FM; Journet AM; Colomb MG
Immunology; 1996 Nov; 89(3):348-55. PubMed ID: 8958046
[TBL] [Abstract][Full Text] [Related]
6. Formation of covalent C3b-tetanus toxin complexes: a tool for the in vitro study of antigen presentation.
Villiers MB; Villiers CL; Wright JF; Maison CM; Colomb MG
Scand J Immunol; 1991 Nov; 34(5):585-95. PubMed ID: 1947794
[TBL] [Abstract][Full Text] [Related]
7. C3b complexation diversifies naturally processed T cell epitopes.
Cretin FC; Serra VA; Villiers MB; Laharie AM; Marche PN; Gabert FM
Mol Immunol; 2007 Apr; 44(11):2893-9. PubMed ID: 17320958
[TBL] [Abstract][Full Text] [Related]
8. OH. treatment of tetanus toxin reduces its susceptibility to limited proteolysis with more efficient presentation to specific T cells.
Pernollet M; Villiers C; Gabert F; Drouet C; Colomb M
Mol Immunol; 1993 Dec; 30(18):1639-46. PubMed ID: 8272077
[TBL] [Abstract][Full Text] [Related]
9. A new role for complement C3: regulation of antigen processing through an inhibitory activity.
Villiers CL; Cretin F; Lefebvre N; Marche PN; Villiers MB
Mol Immunol; 2008 Aug; 45(13):3509-16. PubMed ID: 18585783
[TBL] [Abstract][Full Text] [Related]
10. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells.
Santoro L; Drouet C; Reboul A; Mach JP; Colomb MG
Eur J Immunol; 1994 Jul; 24(7):1620-6. PubMed ID: 8026522
[TBL] [Abstract][Full Text] [Related]
11. Disulfide linkage between C3b and tetanus toxin on tetanus toxin-specific EBV-transformed B cells.
Jacquier MR; Gabert FM; Villiers CL; Colomb MG
J Immunol; 1993 May; 150(10):4253-60. PubMed ID: 8387092
[TBL] [Abstract][Full Text] [Related]
12. Associated complement C3b. Towards an understanding of its intracellular modifications.
Rey-Millet CA; Chesne S; Colomb MG
Mol Immunol; 1993 Jul; 30(10):855-64. PubMed ID: 8341280
[TBL] [Abstract][Full Text] [Related]
13. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
[TBL] [Abstract][Full Text] [Related]
14. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
[TBL] [Abstract][Full Text] [Related]
15. Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity.
Barbey C; Watts C; Corradin G
Eur J Immunol; 1995 Jan; 25(1):30-6. PubMed ID: 7843248
[TBL] [Abstract][Full Text] [Related]
16. [Role of the complement C3 protein in the control of the specific immune response].
Villiers CL; Villiers MB; Marche PN
Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the antibody response by C3b complexed to antigen through an ester link.
Villiers MB; Villiers CL; Laharie AM; Marche PN
J Immunol; 1999 Mar; 162(6):3647-52. PubMed ID: 10092826
[TBL] [Abstract][Full Text] [Related]
18. Distinct protease requirements for antigen presentation in vitro and in vivo.
Matthews SP; Werber I; Deussing J; Peters C; Reinheckel T; Watts C
J Immunol; 2010 Mar; 184(5):2423-31. PubMed ID: 20164435
[TBL] [Abstract][Full Text] [Related]
19. B cell receptors and complement receptors target the antigen to distinct intracellular compartments.
Perrin-Cocon LA; Villiers CL; Salamero J; Gabert F; Marche PN
J Immunol; 2004 Mar; 172(6):3564-72. PubMed ID: 15004157
[TBL] [Abstract][Full Text] [Related]
20. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation.
Erdei A; Spaeth E; Alsenz J; Rüde E; Schulz T; Gergely J; Dierich MP
Mol Immunol; 1984 Dec; 21(12):1215-21. PubMed ID: 6240596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
